Literature DB >> 30995500

GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.

Michael Dougan1, Glenn Dranoff2, Stephanie K Dougan3.   

Abstract

The β common chain cytokines GM-CSF, IL-3, and IL-5 regulate varied inflammatory responses that promote the rapid clearance of pathogens but also contribute to pathology in chronic inflammation. Therapeutic interventions manipulating these cytokines are approved for use in some cancers as well as allergic and autoimmune disease, and others show promising early clinical activity. These approaches are based on our understanding of the inflammatory roles of these cytokines; however, GM-CSF also participates in the resolution of inflammation, and IL-3 and IL-5 may also have such properties. Here, we review the functions of the β common cytokines in health and disease. We discuss preclinical and clinical data, highlighting the potential inherent in targeting these cytokine pathways, the limitations, and the important gaps in understanding of the basic biology of this cytokine family.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GM-CSF; IL-3; IL-5; allergic disease; beta common cytokines; eosinophils; hematopoiesis; tumor immunology

Mesh:

Substances:

Year:  2019        PMID: 30995500     DOI: 10.1016/j.immuni.2019.03.022

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  74 in total

1.  ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation.

Authors:  Yaguang Zhang; Xuezhen Li; Zhongguang Luo; Liyan Ma; Songling Zhu; Zhishuo Wang; Jing Wen; Shipeng Cheng; Wangpeng Gu; Qiaoshi Lian; Xinhao Zhao; Weiguo Fan; Zhiyang Ling; Jing Ye; Songguo Zheng; Dangsheng Li; Hongyan Wang; Jie Liu; Bing Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

2.  Decoding the Body Language of Immunity: Tackling the Immune System at the Organism Level.

Authors:  Nicolas Chevrier
Journal:  Curr Opin Syst Biol       Date:  2019-11-06

3.  A protective signal between the brain's supporting cells in Alzheimer's disease.

Authors:  Jerika J Barron; Anna V Molofsky
Journal:  Nature       Date:  2021-07-14       Impact factor: 49.962

Review 4.  Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.

Authors:  Chiara Crotti; Elena Agape; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

5.  UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia.

Authors:  Tadeusz P Karcz; Gregory S Whitehead; Keiko Nakano; Hideki Nakano; Sara A Grimm; Jason G Williams; Leesa J Deterding; Kenneth A Jacobson; Donald N Cook
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 6.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

7.  Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy.

Authors:  Michael Dougan
Journal:  Cancer Immunol Res       Date:  2020-10       Impact factor: 11.151

8.  Assessment of faithful interleukin-3 production by novel bicistronic interleukin-3 reporter mice.

Authors:  Tracy L Deem; James B Collins; Madison H DeVost; Chandler O Parker; Shelby C Saroka; Ryan J Zoldork; Fernando Gutierrez; Jenny M Russell; Chris S Lantz
Journal:  Immunol Lett       Date:  2020-02-18       Impact factor: 3.685

9.  BHLHE40 Promotes TH2 Cell-Mediated Antihelminth Immunity and Reveals Cooperative CSF2RB Family Cytokines.

Authors:  Nicholas N Jarjour; Tara R Bradstreet; Elizabeth A Schwarzkopf; Melissa E Cook; Chin-Wen Lai; Stanley Ching-Cheng Huang; Reshma Taneja; Thaddeus S Stappenbeck; Steven J Van Dyken; Joseph F Urban; Brian T Edelson
Journal:  J Immunol       Date:  2020-01-03       Impact factor: 5.422

Review 10.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.